The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.
Silver - Individuals: litigation
Recommended - Individuals: transactions
The prominence of the IP team at Red Circle outfit Zhong Lun needs no further introduction – it is one of only two domestic firms in China recommended by the IAM Patent 1000 in all three areas: prosecution, litigation and transactions. This breadth of practice is no surprise given that it is one of China’s largest full-service commercial law groups. Recently, the team has conducted freedom-to-operate analysis for the likes of Pfizer and Abbott Laboratories. Leading on both the mandates is Shanghai-based Helen Cheng, who successfully bridges the gap between the prosecution, litigation and transactional divisions. She has been one of the first names that comes to mind when multinationals need to structure strategic cross-border IP and technology deals. Working alongside her is partner Will Wang, who has joined forces with her in various tech and chemical-related patent infringement suits.
Helen Cheng is a partner in the Shanghai office of Zhong Lun Law Firm. She holds a master’s in science and an LLM from Stanford Law School. In addition to her New York Bar licence, Ms Cheng is admitted to both the Chinese Bar and the Chinese Patent Bar.
Ms Cheng has practised Chinese IP law since 2000. Her practice encompasses all aspects of intellectual property, including trade secret and know-how protection, patent and trademark prosecution, licensing and technology transfers, IP due diligence and dispute resolution in a variety of industries. She has 20 years of first-hand Chinese litigation experience and has represented a number of influential and high-profile IP litigation cases in China. She also has extensive experience in assisting multinational companies in structuring and negotiating cross-border IP and technology-related transactions, such as licensing, strategic alliances and joint ventures. She regularly provides IP consultation to multinational companies on acquiring technology and developing IP strategies for R&D activities in China, including advising on IP policies for R&D-related activities, strategies for trade secret protection and IP enforcement strategies in China.
Ms Cheng was recognised by Chambers and Partners as an Outstanding Young Partner (2014), a Leading Lawyer for IP Litigation (2014-2022) and a Leading Lawyer for Healthcare (2015-2022). She was also named among the Top 15 IP Lawyers in China (2016) by Asian Legal Business. Chambers and Partners states that she has “deep professional knowledge and very solid methodology”. She is praised by clients for “her business acumen as well as her communication skills and strategic approach” and “her understanding as well as quick and accurate grasp of key points, [which] helped her clients achieve their goals”.
Ms Cheng is an adjunct professor at the East China University of Political Science and Law and the Koguan School of Law, Shanghai Jiao Tong University. She has published numerous articles on IP protection in a number of influential periodicals and magazines.